Ayumi Oguma

A Single Subcutaneous Injection of Cellulose Ethers Administered Long before Infection Confers Sustained Protection against Prion Diseases in Rodents

Kenta Teruya, Ayumi Oguma, Keiko Nishizawa et al. · PLoS Pathogens · 2016 · 27 citations · Full text

Neurodegenerative Diseases, Creutzfeldt-jakob Disease, Single Subcutaneous Injection +13

Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion Therapeutics

Mingxuan Ding, Kenta Teruya, Weiguanliu Zhang et al. · Molecular Neurobiology · 2021 · 20 citations · Full text

Efficacy and Mechanism of a Glycoside Compound Inhibiting Abnormal Prion Protein Formation in Prion-Infected Cells: Implications of Interferon and Phosphodiesterase 4D-Interacting Protein

Keiko Nishizawa, Ayumi Oguma, Maki Kawata et al. · Journal of Virology · 2014 · 18 citations · Full text

Pyrene conjugation and spectroscopic analysis of hydroxypropyl methylcellulose compounds successfully demonstrated a local dielectric difference associated with in vivo anti-prion activity

Kenta Teruya, Ayumi Oguma, Keiko Nishizawa et al. · PLoS ONE · 2017 · 13 citations · Full text

Engineering, Immunology, Organic Chemistry +17

Preparation and Characterization of Cellulose Ether Liposomes for the Inhibition of Prion Formation in Prion-Infected Cells

Keiko Nishizawa, Kenta Teruya, Ayumi Oguma et al. · Journal of Pharmaceutical Sciences · 2019 · 11 citations